Recent Quotes (30 days)

You have no recent quotes
chg | %

Accuray Incorporated  

(Public, NASDAQ:ARAY)   Watch this stock  
Find more results for ARAY
5.05
+0.15 (3.06%)
Jan. 12 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 4.90 - 5.05
52 week 3.60 - 6.00
Open 4.90
Vol / Avg. 0.00/1.29M
Mkt cap 422.96M
P/E     -
Div/yield     -
EPS -0.35
Shares 83.75M
Beta 1.29
Inst. own 85%
Jan. 23, 2018
Q2 2018 Accuray Inc Earnings Call - 4:30p.m. EST - Add to calendar
Jan. 23, 2018
Q2 2018 Accuray Inc Earnings Release - 4:00p.m. EST - Add to calendar
Jan. 10, 2018
Accuray Inc at JPMorgan Healthcare Conference - Webcast
Nov. 17, 2017
Accuray Inc Annual Shareholders Meeting (Estimated)
Nov. 17, 2017
Accuray Inc Annual Shareholders Meeting
Oct. 24, 2017
Q1 2018 Accuray Inc Earnings Call - Webcast
Oct. 24, 2017
Q1 2018 Accuray Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep. '17) 2017
Net profit margin -10.32% -7.71%
Operating margin -2.26% -2.56%
EBITD margin - 2.14%
Return on average assets -9.40% -6.76%
Return on average equity -79.07% -55.71%
Employees 944 -
CDP Score - -

Address

1310 Chesapeake Ter
SUNNYVALE, CA 94089-1100
United States - Map
+1-408-7164600 (Phone)
+1-408-7164601 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy. The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

Officers and directors

Louis J. Lavigne Jr. Independent Chairperson of the Board
Age: 69
Bio & Compensation  - Reuters
Joshua H. Levine President, Chief Executive Officer, Director
Age: 53
Bio & Compensation  - Reuters
Elizabeth H. Davila Independent Vice Chairperson of the Board
Age: 73
Bio & Compensation  - Reuters
Kevin Waters Chief Financial Officer, Senior Vice President
Age: 40
Bio & Compensation  - Reuters
Alaleh Nouri Senior Vice President, General Counsel, Corporate Secretary
Age: 38
Bio & Compensation  - Reuters
Lionel Hadjadjeba Senior Vice President, Chief Commercial Officer
Age: 58
Bio & Compensation  - Reuters
Andy Kirkpatrick Senior Vice President - Global Operations
Age: 54
Bio & Compensation  - Reuters
Shig Hamamatsu Vice President, Finance and Chief Accounting Officer, Principal Accounting Officer
Bio & Compensation  - Reuters
Beverly A. Huss Director
Age: 57
Bio & Compensation  - Reuters
Jack Goldstein Ph.D. Independent Director
Age: 70
Bio & Compensation  - Reuters